cGMP Fluorescence In Situ Hybridization (FISH)

WHAT IS FLUORSCENCE IN SITU HYBRIDIZATION (FISH)?


Fluorescence in situ hybridization is used to interrogate specific genomic regions to determine copy number, involvement in translocations or other rearrangements. This technique provides a fuller picture when paired with other whole genome assays such as karyotype or SNP array. From probe design to validation to routine testing, WiCell will be your partner as you work to characterize your cells.

Our highly-trained ASCP (American Society of Clinical Pathology) Certified Analysts and American Board of Medical Genetics and Genomics (ABMGG) board certified or board-eligible directors have provided quality and timely testing results for many years and we now offer a cGMP Compliant FISH service for labs focusing on translational studies and clinical products.

Services are provided in compliance with 21 CFR Part 211 and as Your Lab Partner, WiCell will work with you to make sure the specifics of the testing meet your needs.  Visit our cGMP Testing Services page to learn more about what we can offer with our cGMP compliant characterization services. 

  

INTERPRETING YOUR RESULTS:


Please see our sample cGMP FISH Analysis Report to view an example of the final report.  

As part of our cGMP FISH offering you will also receive a Certificate of Compliance which certifies your testing was completed with current 21 CFR part 211 regulations where applicable. 

Please request more information below and WiCell will talk you through all aspects of your testing goals to make sure that this service fits your needs.